← Back to headlines
Merck Stock Rises as Oncology Strength Outweighs Earnings Guidance Cut
Merck's stock increased as Wall Street investors prioritized the company's strong oncology performance over a cut in its earnings guidance.
4 Aug, 18:31 — 4 Aug, 18:31
Sources
Showing 1 of 1 sources
Related Stories
FDA Approves Groundbreaking New Treatment for Pancreatic Cancer
51m ago
Nutritionists Explain How Dietary Fiber Can Improve Sleep Quality
58m ago
Busy Philipps Reveals Rare Brain Tumor Diagnosis and Two Surgeries
1h ago
Closing Arguments Approach in Murder Trial of Mother Accused of Killing Three Children
2h ago